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Current Opinion
Varicose veins are among the most common chronic disorders
leading to surgical treatment. The definition of varicose
veins varies widely, ranging from “clearly visible, dilated,
tortuous and possibly prominent subcutaneous veins of the
lower extremities” according to Arnoldi,1 to “varicose veins
secondary to loss of valvular efficiency” according to Dodd
and Cockett.2 If one follows the criteria set forth by Arnoldi,
spider veins, telangiectases and varicose veins with valvular
incompetency are collectively considered varicose veins. This
variation in the definition of varicose veins leads to wide
discrepancies in its incidence reported in the literature. In
several reports, the prevalence of varicose veins in adults varied
from 7% to 40% in men and from 14% to 51% in women.3–5
Predisposing factors for varicose veins are now known and,
in a recent population study in Finland, Laurikka and colleagues
reported that increasing age, positive family history of varicose
veins, and childbirth in women were the most important
factors in terms of population aetiological categories.5
Factors associated with varicose veins that draw medical
attention vary, with symptoms ranging from pain, muscle
cramping, or discomfort associated with walking or standing,
to simply cosmetic appearance. Perhaps the most important
question is whether or not these veins affect the patient’s quality
of life. Kurz and colleagues recently reported that impairment
of physical quality of life in patients with varicose veins is
associated with concomitant venous disease rather than the
presence of varicose veins per se.6 In patients with varicose veins
alone, the objective of cosmetic improvement and the
improvement of quality of life should be considered separately.
Despite the common occurrence, the true aetiological cause
of varicose veins remains elusive. The most widely held concept
is that valvular incompetence in the greater saphenous vein
results in venous hypertension and eventual dilatation. In the
last several years, histochemical studies of vein walls have
provided circumstantial evidence of altered connective tissue
metabolism as the primary cause of varicose veins.7,8 Others
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have reported that an increase in metalloproteinase9,10
or urokinase-type plasminogen activator11 may play a role in
varicose vein formation. The hypothesis that a proteolytic
enzyme is involved in the formation of varicose veins
is appealing in light of many studies on the role of metal-
loproteinase in aortic aneurysm formation.
In the last decade, noninvasive and endovascular
technologies have offered new information to patients with
varicose veins. Use of hand-held Doppler or colour duplex
Doppler ultrasonography (US) as a routine test to detect
saphenofemoral reflux prior to surgery has been reported.12,13
In addition, duplex US is used in sclerotherapy to provide
ultrasound guidance for greater injection precision. Because
of the lack of controlled trials, the value of ultrasound-guided
sclerotherapy is open to question. Similarly, the use of duplex
US to detect saphenofemoral reflux as a prerequisite to
vein stripping is also in dispute. Most would agree that, in
experienced hands, proper use of handheld Doppler US and a
thorough clinical examination are sufficient to plan the surgical
procedure. However, duplex US is useful in cases of equivocal
examination or in the evaluation of recurrent varicose veins.
Certainly, duplex US is helpful to determine the status of deep
veins in patients with varicose veins who present with evidence
of ankle pigmentation or ulcer.
Varicose vein surgery began in Byzantine times (324–1453
Common Era) and is probably the oldest vascular surgical
procedure.14 Since then, surgery and sclerotherapy have been
the two main approaches to treatment of varicose veins. It is
well recognized that sclerotherapy is not effective in patients
with saphenofemoral valve incompetence because of the high
rate of late recurrence. The generally accepted method of
choice for surgical treatment is ligation at the saphenofemoral
junction along with long saphenous vein stripping and multiple
local avulsions of vein clusters.
Endovascular technology has emerged as minimally invasive
treatment for vascular disease, and newer techniques such as
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laser treatment,15 radiofrequency saphenous vein occlu-
sion16,17 and transilluminated powered phlebectomy18 have
been introduced to treat varicose veins. The endovascular
radiofrequency technique is of particular interest. The
technique, called VNUS Closure (VNUS Medical Technologies,
Sunnyvale, CA, USA), is a percutaneous catheter-based
procedure in which the long saphenous vein is ablated from
within by resistive heating. Through the catheter, this device
provides continuous impedance and vein wall temperature
feedback to a computer-controlled generator. The controlled
resistive heating causes shortening and thickening of collagen
fibrils, which eventually results in collapse of the vein wall
causing occlusion of the vein. Preliminary studies have shown
the feasibility of this technique for occlusion of the saphenous
vein. A recent report by Merchant and colleagues also
demonstrated results comparable to standard vein stripping in
a multicentre registry.16 However, the report has some
limitations. First, it was not a blinded assessment of outcome
and there was variability in follow-up compliance amongst the
participating centres. Second, there is a learning curve with new
procedures and that may have clouded the results in the early
phase of treatment. Third, there were only 2 years of follow-up
data; therefore, the recurrence rate remains unclear. Neverthe-
less, the report provides useful information on this new
technology. Furthermore, a multicentre trial is needed before
the technique can be accepted to replace standard vein stripping.
Regardless of the treatment technique, varicose vein
recurrence continues to be a challenge for surgeons. With
longer follow-up and frequent use of duplex US, recurrence
rates have been reported to be as high as 60%.19,20 Approximately
40% of these limbs develop clinically distressing new varicosities
and recurrent venous insufficiency symptoms sufficient to
warrant further treatment.21 Even with complete ligation,
transection and care for the saphenofemoral junction
tributaries during initial vein stripping, recurrence can still
happen. Saphenofemoral reflux after surgery continues to
frustrate surgeons. Mechanisms for reconnecting the deep
and superficial venous systems after successful saphenofemoral
ligation are transnodal lymphovenous connections,
enlargement of femoral venules, and stump-related or field-
related neovascularity.21 Neovascularization is a relatively new
concept and its mechanism remains ill-defined. How and
where the cells regenerate remains unknown. Some
investigators suggest the use of an impermeable barrier such
as expanded polytetrafluoroethylene (PTFE) overlying the
femoral vein to prevent neovascularization.22 The potential
for this technique needs further study.
In the majority of cases, varicose veins are a benign
condition. Prevention of the occurrence of varicose veins is
most unlikely. With the increasing age of the population and
the high recurrence rates, varicose veins will continue to be a
burden to the healthcare system. More studies on varicose
veins are needed to provide better care to this patient
population.
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